MENU
DMAC
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
DiaMedica Therapeutics (DMAC) Earnings Date & Reports
DiaMedica Therapeutics Inc is a clinical-stage biopharmaceutical company... Show more
Industry: #Biotechnology
A.I. Advisor
published Earnings
DMAC is expected to report earnings to rise 12.32% to -21 cents per share on November 18
Q3'26
Est.
$-0.21
Q2'26
Est.
$-0.19
Q1'26
Est.
$-0.19
Q4'25
Est.
$-0.17
Q3'25
Est.
$-0.17
The last earnings report on August 10 showed earnings per share of -18 cents, meeting the estimate of -18 cents. With 124.16K shares outstanding, the current market capitalization sits at 448.66M.
View a ticker or compare two or three
VS
VS
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a developer of novel therapeutic compounds for diabetes and other diseases
Industry Biotechnology
Industry
Biotechnology
Address
301 Carlson Parkway
Phone
+1 763 496-5454
Employees
35
Web
https://www.diamedica.com